Clinical Trial Update: Donafenib Combined With Hepatic Artery Chemoembolization for Perioperative Treatment of Liver Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating donafenib in combination with hepatic artery chemoembolization as perioperative treatment in liver transplantation for hepat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Donafenib (donafenib)

Snippet

Sponsor: Beijing Tsinghua Chang Gung Hospital | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN